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1. Introduction 
Deficiency of glucose 6-phosphate dehydrogenase 
(G-6-PD)* (EC 1 .l. 1.49) in red cells is often accom 
panied by a reduced survival time of these cells. The 
consequence of G-6-PD deficiency in erythrocytes is 
quite well understood, whereas the mechanism of 
reduced G-6-PD activity at the molecular level is not 
known. In two variants, G-6-PD A’ [l] and G-6-PD 
Hektoen [2] single amino acid substitutions could be 
demonstrated. But till now this alteration of the 
primary structure could not explain the impaired 
function of this enzyme. Ratazzi et al. [3] have sug- 
gested, that in some G-6-PD variants amino acid 
mutations affect the association or a cooperative 
effect of the subunits of G-6-PD, whereas in others 
the structural abnormality affects the activity of the 
subunits themselves. 
Modification of G-6-PD activity has been reported 
in single variants of red cell G-6-PD. In 1960 Rimon 
et al. [4] showed that stroma of erythrocytes with 
normal G-6-PD activity enhanced the low activity in 
some mutants of G-6-PD in patients of Jewish descent. 
These findings, however, were not confirmed later by 
immunological methods [5]. Recently Kahn et al. 
[6] observed an activation of the G-6-PD Benevento- 
like variant by incubating the enzyme with an anti- 
body specific for normal G-6-PD. 
We have reported recently a new G-6-PD variant 
associated with chronic nonsphaerocytic haemolytic 
anaemia, G-6-PD Hamburg [7]. In this paper we 
* Abbrevations: G-6-PD, glucose 6-phosphate dehydrogenase; 
G-6-P, glucose-6-phosphate. 
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describe an inhibitory effect of this variant on normal 
G-6-PD activity and the results of several experiments 
to elucidate the nature of this inhibition. 
2. Materials and methods 
2.1. Determinatiorz of’G-6-PD actkity, eilzyme 
corlstants arzd protein concerztration 
G-6-PD activity was determined according to 
Beutler [8j . In a final vol of 1 .O ml the incubation 
mixture contained 0.2 pmol NADP, 0.6 pmol G-6-P, 
10 pmol MgCl* , 0.1 mmol Tris-HCl, pH 8.0, and 
varying amounts of haemolyzate or partially purified 
enzyme. K, values and V,, were determined accord- 
ing to the method of Lineweaver and Burk [9]. 
Protein concentration was determined by the standard 
calorimetric method [lo] using human albumin as a 
standard. 
2.2. Procedure of partial purification of G-dPD 
Erythrocytes were haemolyzed by the addition of 
two vol 5 mM sodium phosphate buffer pH 6.4 with 
1 mM EDTA, 1 mM mercaptoethanol and 20 PM NADP 
and 0.2 vol chloroform. G-6-PD was partially purified 
according to the recommendations of the WHO 
scientific group [ 1 l] and after the method of Ratazzi 
et al. [3]. Instead of DEAE-cellulose DEAE-Sephadex 
was used for the first step of purification. Then the 
enzyme was precipitated by 50% ammonium sulphate 
and dialyzed against 50 mM Tris-HCl pH 8.0 with 
0.27 mM EDTA, 7 mM mercaptoaethanol and 10 PM 
NADP at least 24 h in the cold with change of buffer 
every 8 h. The specific activity of the partially purified 
normal enzyme was consistently in the range of 2 IU 
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per mg protein. G-6-PD Hamburg which had no mea- 
surable enzymatic activity in the haemolyzate had a 
specific activity of 0.0027 IU per mg protein after the 
purification procedure. The partially purified enzymes 
had no detectable 6-phosphogluconate dehydrogenase 
activity. The properties of the variant enzyme, G-6-PD 
Hamburg, have already been reported [7]. 
2.3. Other methods 
For gel filtration with Sephadex G-25 a short 
column of 9 cm in length and 0.9 cm in diameter was 
used. The buffer was that of dialysis. Plasma of the 
patient was obtained after centrifugation of titrated 
blood for 15 min at SOOOg in the cold. 0.5 ml of 
plasma was added to the assay mixture for G-6-PD 
activity. Stroma of the patient’s erythrocytes was 
prepared by haemolyzing his red cells in 0.27 mM 
EDTA, 10 mM mercaptoaethanol and 0.1 mM NADP. 
After centrifugation for 20 min at 20 000 g the stroma 
was resuspended in the haemolyzing solution. 0.5 ml 
of the stroma suspension was added to the assay 
nkture for G-6-PD when indicated. 
3. Results 
3.1. Mode of inhibition 
Addition of haemolyzate, prepared from erythro- 
cytes of the patient with G-6-PD Hamburg, or partially 
purified G-6-PD Hamburg preparation to normal 
G-6-PD inhibits its activity immediately. The inhibition 
could be observed between pH 6.5 and pH 9.0 always 
by the same amount. The degree of inhibition depends 
on the amount of G-6-PD Hamburg either as haemo- 
lyzate or as partially purified preparation added to 
the normal enzyme. The effect of increasing amounts 
of partially purified G-6-PD Hamburg on the catalytic 
activity of the normal partially purified enzyme is 
shown in fig.1. The resulting curve is sigmoid shaped. 
Similar curves were seen after the additition of 
haemolyzate with G-6-PD Hamburg to partially puri- 
fied normal enzyme or of partially purified G-6-PD 
Hamburg to haemolyzate containing normal enzyme. 
The inhibitory effect could be demonstrated on 
partially purified G-6-PD preparations from six 
different blood donors. On the other hand, purified 
G-6-PD A- and purified preparations of two new 
G-6-PD variants (not yet published) did not inhibit 
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Fig.1. Inhibition of normal G-6-PD by G-6-PD Hamburg. 
Different amounts of partially purified G-6-PD Hamburg 
were added to a constant amount of partially purified normal 
G-6-PD. Normal G-6-PD activity without G-6-PD Hamburg 
added is taken as 100%. The specific activity of partially 
purified G-6-PD Hamburg was 0.0027 IU per mg protein. 
The protein concentration was 270 ).r.g/ml. 
normal, partially purified G-6-PD nor G-6-PD activity 
in normal haemolyzates. 
In order to characterize the nature of this inhibition 
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Fig.2. Lineweaver-Burk plot for the determination of the 
type of inhibition of normal G-6-PD by G-6-PD Hamburg. 
Michaelis--Menten kinetics for G-6-P of normal partially 
purified G6-PD were determined without and in the presence 
of two different amounts of partially purified G-6-PD 
Hamburg. (o---o) without G-6-PD Hamburg; (o-o) with 
0.06 ml G-6-PD Hamburg; (*--0) with 0.07 ml G-6-PD 
Hamburg added. The graph demonstrates a non-competitive 
inhibition. 
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Table 1 
Effect of treatment of partially purified preparations of G-6-PD Hamburg on the 
inhibition of normal partially purified G-6-PD by G-6-PD Hamburg 
Treatment of partially 
purified G-6-PD Hamburg 
._ 
___ 
Activity of normal G-6-PDa in 
the presenceb of G-6-PD Hamburg 
before and after the indicated 
treatment of G-6-PD Hamburg 
Before After 
Column chromatography with 
Sephadex G-25 
Dialysis for 24 h 
Addition of diisopropylfluoro- 
phosphate (5 X lo-’ M) 
Addition of e-amino caproic 
acid (2 x 10m3 M) 
Heating (65°C for 30 min) 
Heating (40°C for 30 min) 
0.39 0.42 
0.44 0.46 
0.48 0.39 
0.47 0.46 
0.42 1.04 
0.37 0.40 
-._ 
a Enzyme activities are expressed in IU per mg protein. 
b The amount of G-6-PD Hamburg added produced a 50% inhibition of normal 
G-6-PD activity. 
the KM value for G-6-P and the V,,, of the reaction 
of the normal, partially purified enzyme in the 
presence of different amounts of partially purified 
G-6-PD Hamburg was determined. Fig.2 shows that 
the KM value for G-6-P is not altered by the addition 
of G-6-PD Hamburg, whereas the maximal velocity 
was diminished; this indicates that the inhibition is 
non-competitive. As a result, high concentrations of 
the substrate G-6-P (0.2 M) could not overcome the 
inhibitory effect. The same experiment with the other 
substrate NADP also revealed a non-competitive 
inhibition. 
3.2. Experiments characterizing the nature of the 
inhibitory factor 
Column chromatography with Sephadex G-25 and 
dialysis did not remove the inhibiting action of the 
partially purified preparation of G-6-PD Hamburg on 
the normal, partially purified enzyme (table 1). 
Heating, however, of the partially purified G-6-PD 
Hamburg preparation at 65°C for 30 min abolished 
the inhibitory effect. Dialyzate of G-6-PD Hamburg 
had no inhibitory effect on the activity of normal, 
partially purified G-6-PD, when the mutant enzyme 
prior to dialysis was heated 30 min at 65°C. Both, 
haemolyzate and the partially purified fraction of 
G-6-PD Hamburg, inhibited the activity of normal 
G-6-PD. Whether or not the degree of inhibition 
is a function of its state of purification, i.e. of an 
increase in specific activity, cannot be answered, since 
there was no measurable activity in the haemolyzate 
of G-6-PD Hamburg. However, after partial purification 
of G-6-PD Hamburg the inhibiting effect per mg 
protein increased. Since the activity of G-6-PD is 
determined by the amount of NADPH formed, an 
enzyme oxidizing this compound in the erythrocytes 
of our patient could be responsible for the observed 
inhibition of normal G-6-PD activity. To test this 
possibility partially purified G-6-PD Hamburg was 
incubated under conditions used for the assay of, 
G-6-PD activity as described under Material and 
Methods, except that NADP was omitted and was 
replaced by 0.2 pmol NADPH. Oxidation of NADPH 
was not observed in the presence of G-6-PD Hamburg. 
Plasma or stroma of the erythrocytes from the patient 
with G-6-PD Hamburg had no inhibitory effect on 
normal G-6-PD activity. Inhibitors of proteases 
(diisopropylfluorophosphate, e-amino caproic acid) 
did not abolish the inhibiting action of G-6-PD 
Hamburg on normal G-6-PD (table 1). 
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4. Discussion 
In this paper we describe the inhibition of normal 
G-6-PD activity by a partially purified preparation of 
a mutant enzyme, G-6-PD Hamburg. This inhibition 
is a non-competetive one. The true nature of the 
inhibitor could so far not be elucidated. Since the 
inhibiting action is not eliminated by dialysis or gel 
filtration, it appears to be linked to a protein. It seems 
that the inhibition of the partially purified preparation 
of G-6-PD Hamburg on normal G-6-PD activity is not 
altered by the process of purification and thus intrin- 
sic to the enzyme protein. So a possible explanation 
for the observed effect could be an exchange of sub- 
units. For normal G-6-PD, a polymeric enzyme com- 
posed of identical subunits, it has been shown that at 
pH 8.0 and in the presence of NADP an equilibrium 
exists between the dimeric, catalytic active and the 
monomeric form, which has no enzymatic activity 
[12]. By the assumption, that also the variant enzyme 
G-6-PD Hamburg at the same pH and the same molar 
concentration of NADP exists partly in the monomeric 
form, the inhibition could be due to an exchange of 
monomers between normal and variant enzyme. There 
are some arguments against this hypothesis: (1) The 
inhibition is observed in the same range after lowering 
the pH to 6.5. At this pH normal G-6-PD exists as a 
stable tetramer which cannot exchange subunits [ 121. 
(2) The inhibition could be demonstrated very rapidly 
after the addition of mutant to normal enzyme. This 
fact also does not support the hypothesis of exchange 
of subunits as the basis for the observed inhibition, 
because hybridization of G-6-PD subunits takes a 
longer time to occur [ 12,131 
There are other possible reasons for the observed 
inhibition of normal G-G-PD activity by the partially 
purified preparation of G-6-PD Hamburg. Absorption 
of an inhibitor to the variant G-6-PD molecule, whose 
action is abolished by the process of heating, could 
be responsible for the inhibition. Removal of ‘structu- 
ral’ NADP, which is a regulating factor for the equi- 
librium between dimers and monomers [ 141, results 
in the dissociation of the dimeric enzyme to monomers 
[ 151 . To explain the inhibition of normal G-6-PD by 
G-6-PD Hamburg on this basis, we have to assume 
that G-6-PD Hamburg has such an effect on the 
‘structural’ NADP of the normal enzyme. This would 
result in an increased number of catalytic inactive 
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monomers from normal G-6-PD and so to a decreased 
total catalytic activity. This hypothesis, however, 
cannot be supported by facts. The non-competetive 
inhibition of normal G-6-PD activity by the partially 
purified preparation of G-6-PD Hamburg might be 
explained by factors destroying the normal G-6-PD 
molecule. The presence of a proteolytic enzyme 
specific for G-6-PD activity could be compatible with 
the reported results. Inhibitors of proteases, however, 
were not able to prevent the inhibition. 
To elucidate the true mechanism of the observed 
inhibition it is necessary to obtain the variant enzyme 
G-6-PD Hamburg in a highly purified state. This, 
however, is not possible by the use of currently 
available techniques. 
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